Titan Biotech Q2 FY27 Results: Net Profit ₹12.5 Cr, Up 60.3% YoY
Titan Biotech Ltd reported revenue from operations of ₹76.5 Cr (+40.6% YoY) and net profit of ₹12.5 Cr (+60.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12.5 Cr · +60.3% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Titan Biotech Ltd reported revenue from operations of ₹76.5 Cr (+40.6% YoY) and net profit of ₹12.5 Cr (+60.3% YoY) for Q2 FY27.
Titan Biotech Ltd reported revenue from operations of ₹59.2 Cr (+27.3% YoY) and net profit of ₹10.9 Cr (+58.0% YoY) for Q1 FY27.
Titan Biotech Ltd reported revenue from operations of ₹48.8 Cr (+38.6% YoY) and net profit of ₹6.7 Cr (+67.5% YoY) for Q4 FY26.
Titan Biotech Limited approved its audited financial results for the fiscal year ended March 31, 2026. The Board also recommended a dividend of Rs. 0.50 per share.